Pharmaceutical companies fight marijuana legalization to keep patients addicted to opioid painkillers
by: PF Louis
NaturalNews.com
Wednesday, January 27, 2016
The U.S. Drug Enforcement Agency (DEA) is constantly finding ways to bypass state laws that sanction medical marijuana and harass providers who are operating under those state laws. They are overt and obvious with their application of federal laws.
The Drug Enforcement Administration (DEA), which operates under the U.S. Department of Justice (DOJ), still classifies marijuana as a Schedule 1 drug, a rating that classifies it medicinally useless, dangerous, and addictive. Strangely, the pharmaceutical drugs that are the most dangerous and addictive are Big Pharma’s expensive and toxic opiate based pain killers.
Big Pharma produced opiates have official medical merit as Food and Drug Administration (FDA) approved pain killers. Most of them are Schedule II and III on the DEA list. But, if doctor prescribed, they’re okay. Fake prescriptions or multiple prescriptions are methods of choice used by addicts to obtain oxycodone pain killers such as OxyContin.
One such addict was former Rhode Island Representative Patrick Kennedy, son of the late Senator Ted Kennedy. His career ending episode in 2006 of crashing into a Capitol Hill barricade while under the influence of OxyContin led to discovering his history of prescription drug abuse.
After rehab he became an anti-marijuana crusader, even though his problem centered on addiction to pharmaceutical drugs. A key speaker at an early 2014 Community Anti-Drug Coalition of America (CADCA) rally, he urged the 2,000 people present to spread the word of marijuana’s evils.
“Let me tell you, there is nothing more inconsistent with trying to improve mental health and reduce substance-abuse disorders in this country than to legalize a third drug,” bellowed Kennedy. Purdue Pharma, maker of OxyContin, was a major sponsor for this CADCA event.
Exposing who finances anti-marijuana movements
The Rest…HERE